Relationship between serum insulin-like growth factor-1, IGF binding protein-3 levels and body height before and after gonadotropin-releasing hormone agonist therapy

키워드

참고문헌 (31)

1. Grumba ch MM, "Williams textbook of endocrinology", pp.1509~625 (1998), Saunders
2. Chalumeau M, "Central precocious puberty in girls: an evidence-based diagnosis tree to predict central nervous system abnormalities", Pediatrics, 109, pp.61~67 (2002)
3. Mogensen SS, "Diagnostic work-up of 449 consecutive girls who were referred to be evaluated for precocious puberty", J Clin Endocrinol Metab, 96, pp.1393~1401 (2011)
4. 김한결, "Gonadotropin-releasing Hormone Stimulation Test for Precocious Puberty", Annals of Laboratory Medicine, 31(4), pp.244~249 (2011), 대한진단검사의학회
5. Weise M, "Effects of estrogen on growth plate senescence and epiphyseal fusion", Proc Natl Acad Sci USA, 98, pp.6871~6876 (2001)
6. Byers S, "Quantitative histomorphometric analysis of the human growth plate from birth to adolescence", Bone, 27, pp.495~501 (2000)
7. Carel JC, "Precocious puberty and statural growth", Hum Reprod Update, 10, pp.135~147 (2004)
8. Crowley WF Jr, "Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty", J Clin Endocrinol Metab, 52, pp.370~372 (1981)
9. Attie KM, "The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency:evidence for a direct role of sex steroids", J Clin Endocrinol Metab, 71, pp.975~983 (1990)
10. Cara JF, "Growth hormone deficiency impedes the rise in plasma insulin-like growth factor I levels associated with precocious puberty", J Pediatr, 115, pp.64~68 (1989)
11. Partsch CJ, "Management and outcome of central precocious puberty", Clin Endocrinol, 56, pp.129~148 (2002)
12. Adan L, "Factors predicting adult height in girls with idiopathic central precocious puberty: implications for treatment", Clin Endocrinol, 56, pp.297~302 (2002)
13. Paul D, "Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5years", J Clin Endocrinol Metab, 80, pp.546~551 (1995)
14. Allali S, "Predicting the adult height of girls with central precocious puberty", Med Sci Monit, 17, pp.PH41~PH48 (2011)
15. Kauli R, "Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method", Horm Res, 47, pp.54~61 (1997)
16. Oerter KE, "Adult height in precocious puberty after longterm treatment with deslorelin", J Clin Endocrinol Metab, 73, pp.1235~1240 (1991)
17. Greulich WW, "Radiographic atlas of skeletal development of hand wrist" (1971), Stanford University Press
18. Cole TJ, "The LMS method for constructing normalized growth standards", Eur J Clin Nutr, 44, pp.45~60 (1990)
19. 2007 Korean children and adolescents growth standard (commentary for the development of 2007 growth chart), "Korea Centers for Disease Control and Prevention", Korea Centers for Disease Control and Prevention, ~ (2007)
20. Hyun SE, "Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3in Korean children and adolescents", Clin Biochem, 45, pp.16~21 (2012)
21. Harris DA, "Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist", J Clin Endocrinol Metab, 61, pp.152~159 (1985)
22. DiMartino-Nardi J, "The effect of long-acting analog of luteinizing hormone-releasing hormone on growth hormone secretory dynamics in children with precocious puberty", J Clin Endocrinol Metab, 73, pp.902~906 (1991)
23. 이경희, "성선자극호르몬방출호르몬 유도체 치료를 받는 진성성조숙증 여아의 1년간 IGF-1, IGFBP-3 혈중농도의 변화", Annals of Pediatirc Endocrinology & Metabolism, 16(1), pp.20~23 (2011), 대한소아내분비학회
24. Kanety H, "Insulinlike growth factor-I and IGF binding protein-3 remain high after GnRH analogue therapy in girls with central precocious puberty", Clin Endocrinol, 45, pp.7~12 (1996)
25. Sklar CA, "Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion", J Clin Endocrinol Metab, 73, pp.734~738 (1991)
26. Belgorosky A, "Serum IGF-I during treatment of three different types of abnormal puberty, possible role of IGF-I in pubertal maturation", Proceedings of the 76th Annual Meeting of the Endocrine Society (1994), The Endocrine Society
27. Weise M, "Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty", J Clin Endocrinol Metab, 89, pp.103~107 (2004)
28. 이승재, "Effects of Gonadotropin-Releasing Hormone Agonist Therapy on Body Mass Index and Height in Girls with Central Precocious Puberty", 전남의대학술지, 48(1), pp.27~31 (2012), 의과학연구소
29. Bouvattier C, "Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized longterm pilot study", J Clin Endocrinol Metab, 84, pp.3575~3578 (1999)
30. Cassio A, "Randomised trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5-8.5 years", Arch Dis Child, 81, pp.329~332 (1999)
31. Badaru A, "Sequential comparisons of onemonth and three-month depot leuprolide regimens in central precocious puberty", J Clin Endocrinol Metab, 91, pp.1826~1867 (2006)

관련 논문AI추천